Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study

OBJECTIVES: To better understand the real-world impact of biologic therapy in persons with Crohn’s disease (CD) and ulcerative colitis (UC), we evaluated the effect of marketplace introduction of infliximab on the population rates of hospitalisations and surgeries and public payer drug costs. DESIGN...

Descripción completa

Detalles Bibliográficos
Autores principales: Murthy, Sanjay K, Begum, Jahanara, Benchimol, Eric I, Bernstein, Charles N, Kaplan, Gilaad G, McCurdy, Jeffrey D, Singh, Harminder, Targownik, Laura, Taljaard, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984056/
https://www.ncbi.nlm.nih.gov/pubmed/31196874
http://dx.doi.org/10.1136/gutjnl-2019-318440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984056/
https://www.ncbi.nlm.nih.gov/pubmed/31196874
http://dx.doi.org/10.1136/gutjnl-2019-318440

Ejemplares similares